Stocktoria

Tenon Medical, Inc. TNON

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2022-04-27

Tenon Medical, Inc. (TNON) earns a Piotroski F-score of 4/9 (mixed financial health). It does not currently pay a dividend. FY2025 revenue was $3.9M at a -318.4% net margin.

Chart by TradingView
26/100
Stocktoria Quality Score · grade D
4/9
Piotroski F — financial health
Altman Z″ — distress risk
Dividend yield · no dividend
-1.73
Beneish M-score — earnings quality · elevated

Quality score trend · recomputed for each fiscal year

Piotroski F /9
3 4 4 4 2022202320242025
Altman Z″
-17.57 2022202320242025

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

$5.64 as of 2026-08-12 · -86.3% 1y
$5.64$42.0052-wk

Beneish M-score: -1.73 — elevated (above the −1.78 line — aggressive-accounting signals worth a closer look) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.

Market cap USD$6M
Net margin 5y avg-1682.1%
Return on equity 5y avg-695.9%
Beta1.26
Employees26

Analyst price target

$2.62 -53.5% vs last
· 2 analysts
target range $2.25 – $3.00

Wall Street analyst consensus — a sentiment gauge, not our scoring.

Revenue trend · last 5y · up

How it ranks in Manufacturing · percentile among 1957 companies

Piotroski Fstronger than 45%
Net marginstronger than 16%
Return on equitystronger than 7%

Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 4/9 tests passed

Sector peers · similar-size Manufacturing companies compare side by side →

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
TNONTenon Medical, Inc.4/9
AURXNuo Therapeutics, Inc.3/9
LUCDLucid Diagnostics Inc.3/9
INBSINTELLIGENT BIO SOLUTIONS INC.2/9
OSRHOSR Health, Inc.1.04
USAQQHSLab, Inc.4/9-1.02
PSTVPLUS THERAPEUTICS, INC.3/9

All Manufacturing companies →

About Tenon Medical, Inc.

Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive inferior-posterior approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along its longitudinal axis. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.

FAQ

Is TNON financially healthy?

Tenon Medical, Inc.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak).

Does TNON pay a dividend?

No, Tenon Medical, Inc. does not currently pay a dividend.

How profitable is TNON?

In FY2025, Tenon Medical, Inc. had a net margin of -318.4% and a return on equity of -249.1%.

What is the analyst price target for TNON?

The average Wall-Street price target for Tenon Medical, Inc. is $2.62, about 53.5% below the recent price, from 2 analysts.

Is TNON a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on Tenon Medical, Inc.: a Piotroski F-score of 4/9. Weigh these quality and valuation signals against your own goals.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.